BOTTA, CIRINO
 Distribuzione geografica
Continente #
EU - Europa 970
NA - Nord America 916
AS - Asia 142
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 2.031
Nazione #
US - Stati Uniti d'America 915
GB - Regno Unito 430
IE - Irlanda 168
IT - Italia 110
CN - Cina 89
SE - Svezia 73
UA - Ucraina 59
DE - Germania 40
FR - Francia 30
FI - Finlandia 18
VN - Vietnam 18
IN - India 15
BE - Belgio 14
ES - Italia 14
TR - Turchia 14
IM - Isola di Man 7
IR - Iran 3
AT - Austria 2
HK - Hong Kong 2
PL - Polonia 2
RU - Federazione Russa 2
AU - Australia 1
BD - Bangladesh 1
CA - Canada 1
CL - Cile 1
LT - Lituania 1
ZA - Sudafrica 1
Totale 2.031
Città #
Southend 403
Dublin 161
Fairfield 127
Chandler 74
Ashburn 73
Ann Arbor 66
Wilmington 63
Woodbridge 56
Jacksonville 55
Seattle 54
Siena 49
Cambridge 46
Menlo Park 45
Houston 43
Beijing 26
Princeton 24
New York 22
Dearborn 18
Dong Ket 18
Fremont 18
Brussels 14
Nanjing 14
Helsinki 13
Izmir 13
Málaga 12
San Mateo 10
Boardman 9
Douglas 7
Falls Church 7
Florence 7
Lancaster 7
Hebei 6
San Diego 6
Shanghai 6
Shenyang 6
Nanchang 5
Tianjin 5
Jinan 4
Fuzhou 3
Hangzhou 3
London 3
Mumbai 3
Napoli 3
Phoenix 3
Zhengzhou 3
Bari 2
Duncan 2
Hong Kong 2
Leawood 2
Sezze 2
Turin 2
Ventimiglia 2
Vienna 2
Villamagna 2
Zanjan 2
Alghero 1
Andover 1
Bangalore 1
Borghetto Lodigiano 1
Campi Bisenzio 1
Canberra 1
Carraia 1
Certaldo 1
Changsha 1
Delhi 1
Dhaka 1
Eboli 1
Edinburgh 1
Falkenstein 1
Foligno 1
Galatone 1
Gauteng 1
Girona 1
Giussano 1
Henderson 1
Hounslow 1
Katowice 1
Kilburn 1
Kocaeli 1
Kunming 1
Kyiv 1
Massa 1
Messina 1
Modena 1
Ningbo 1
Paiporta 1
Philadelphia 1
Prato 1
Redwood City 1
Saint Louis 1
Taizhou 1
Warsaw 1
Washington 1
Winnipeg 1
Totale 1.672
Nome #
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 239
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine 230
Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients 224
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 207
Immuno-Inflammatory Markers in Advanced NSCLC Patients Undergone Fractioned Cisplatin, Oral Etoposide and Bevacizumab 171
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 164
Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients 162
Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). 144
Tumor infiltration by T lymphocytes correlates with the outcome of prostate cancer patients treated with salvage radiotherapy 141
Design, synthesis, structure, and photophysical features of highly emissive cinnamic derivatives 118
Immune-inflammatory markers predict the outcome of metastatic colorectal cancer patients treated with the thymidylate synthase poly-epitope peptide (TSPP) vaccine: results from a multi-arm TSPP/VAC phase lb program 115
null 107
PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach 57
Synthesis, photophysical and photochemical features of a Morita-Baylis-Hillman adduct derivative bearing a triphenylamine moiety 6
Totale 2.085
Categoria #
all - tutte 5.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.273


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019135 0 0 0 0 0 0 0 0 0 0 71 64
2019/2020416 50 9 26 44 31 46 44 44 46 40 16 20
2020/2021423 18 44 8 35 32 52 13 53 42 68 19 39
2021/2022249 12 25 19 17 24 13 18 12 25 25 20 39
2022/2023268 17 27 39 36 25 49 9 19 18 17 8 4
2023/2024255 8 6 19 14 5 72 119 4 3 4 1 0
Totale 2.085